Surface antigen expression and correlation with variable heavy-chain gene mutation status in chronic lymphocytic leukemia

European Journal of Haematology

Volumn 70, Issue 1, 2003, Pages 53-59

  Vilpo, Juhani ^a,c   Tobin, Gerard ^b   Hulkkonen, Janne ^a   Hurme, Mikko ^a   Thunberg, Ulf ^b   Sundström, Christer ^b   Vilpo, Leena ^a   Rosenquist, Richard ^b  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^b UPPSALA UNIVERSITY   (Sweden)

^c JORVI HOSPITAL   (Finland)

Author keywords

Chronic lymphocytic leukemia; Immunoglobulin gene; Somatic hypermutation; Surface membrane antigen

Indexed keywords

CD45 ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; LEUKOCYTE ANTIGEN; MEMBRANE ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA SPLICING;

ANTIGENS, SURFACE; BIOLOGICAL MARKERS; GENE REARRANGEMENT; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MUTATION; POLYMERASE CHAIN REACTION; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 12244270405     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2003.02838.x     Document Type: Article

References (35)

1. GHIA P, CALIGARIS-CAPPIO F. The origin and nature of chronic lymphocytic leukemia lymphocyte. In: CHESON, B, ed. Chronic Lymphoid Leukemias. New York: Marcel Dekker, Inc, 2001: 63-80.
2. BENNETT J, CATOVSKY D, DANIEL M, et al. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J Clin Pathol 1989;42:567-584.
3. MATUTES E, OWUSU-ANKOMAH K, MORILLA R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994;8:1640-1645.
4. KIPPS TJ, TOMHAVE E, PRATT LF, DUFFY S, CHEN PP, CARSON DA. Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1989;86:5913-5917.
5. DEANE M, NORTON JD. Preferential rearrangement of developmentally regulated immunoglobulin VH1 genes in human B-lineage leukaemias. Leukemia 1991;5:646-650.
6. EBELING SB, SCHUTTE ME, AKKERMANS-KOOLHAAS KE, BLOEM AC, GMELIG-MEYLING FH, LOGTENBERG T. Expression of members of the immunoglobulin VH3 gene families is not restricted at the level of individual genes in human chronic lymphocytic leukemia. Int Immunol 1992;4:313-320.
7. SCHROEDER HW Jr, DIGHIERO G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire [see comments]. Immunol Today 1994;15:288-294.
8. OSCIER DG, THOMPSETT A, ZHU D, STEVENSON FK. Differential rates of somatic hypermutation in V (H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. Blood 1997;89:4153-4160.
9. FAIS F, GHIOTTO F, HASHIMOTO S, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998;102:1515-1525.
10. HAMBLIN TJ, DAVIS Z, GARDINER A, OSCIER DG, STEVENSON FK. Unmutated Ig V (H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848-1854.
11. DAMLE RN, WASIL T, FAIS F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94:1840-1847.
12. TOBIN G, THUNBERG U, JOHNSON A, et al. Somatically mutated Ig VH3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 2002;99:2262-2264.
13. HAMBLIN TJ, ORCHARD JA, GARDINER A, OSCIER DG, DAVIS Z, STEVENSON FK. Immunoglobulin V genes and CD38 expression in CLL. Blood 2000;95:2455-2457.
14. THUNBERG U, JOHNSON A, ROOS G, et al. CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia. Blood 2001;97:1892-1894.
15. KLEIN U, TU Y, STOLOVITZKY GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 2001;194:1625-1638.
16. ROSENWALD A, ALIZADEH A, WIDHOPF G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001;194:1639-1647.
17. HULKKONEN J, VILPO L, HURME M, VILPO J. Surface antigen expression in chronic lymphocytic leukemia, clustering analysis, irrelationships and effects of chromosomal abnormalities. Leukemia 2002;16:178-185.
18. VILPO J, HULKKONEN J, HURME M, VILPO L. Surface membrane antigen expression changes induced in vitro by exogenous growth factors in chronic lymphocytic leukemia cells. Leukemia 2002;16:1691-1698.
19. KARHU R, VILPO LI, ISOLA J, KNUUTILA S, VILPO J. Cryopreserved chronic lymphocytic leukaemia cells analysed by multi-colour FISH after optimised mitogen stimulation. Genes Chromosom Cancer 2002;34:345-348.
20. KARHU R, KNUUTILA S, KALLIONIEMI OP et al. Frequent loss of the 11q14-24 region in chronic lymphocytic leukemia: a study by comparative genomic hybridization. Tampere CLL Group Genes Chromosom Cancer 1997;19:286-290.
21. LARRAMENDY M, SIITONEN S, ZHU Y, et al. Optimized mitogen stimulation induces proliferation of neoplastic B-cells in chronic lymphocytic leukemia: significance for cytogenetic analysis. Cytogen Cell General 1998;82:215-221.
22. ZHU Y, MONNI O, EL-RIFAI W, et al. Discontinuous deletions at 11q23 in B-cell chronic lymphocytic leukemia. Leukemia 1999;13:708-712.
23. LI AH, ROSENQUIST R, FORESTIER E, et al. Clonal rearrangements in childhood and adult precursor B acute lymphoblastic leukemia: a comparative polymerase chain reaction study using multiple sets of primers. Eur J Haematol 1999;63:211-218.
24. MADDY AH, SANDERSON A, MACKIE MJ, SMITH SK. The role of cell maturation in the generation of phenotypic heterogeneity in B-cell chronic lymphocytic leukaemia. Immunology 1989;68:346-352.
25. + B cells and helper T cells in immunoglobulin production. Eur J Immunol 1997;27:2073-2079.
26. + peripheral blood cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exptl Med 1998;188:1679-1689.
27. TANGYE S, LIU Y, AVERSA G, PHILLIPS J, DE VRIES J. Identification of functional human splenic memory B cells by expression of CD148 and CD27. J Exptl Med 1998;188:1691-1703.
28. DAMLE RN, GHIOTTO F, VALETTO A, et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood 2002;99:4087-4093.
29. HAMBLIN TJ, ORCHARD JA, IBBOTSON RE, et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 2002;99:1023-1029.
30. KROBER A, SEILER T, BENNER A, et al. V (H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002;100:1410-1416.
31. JENSEN GS, POPPEMA S, MANT MJ, PILARSKI LM. Transition in CD45 isoform expression during differentiation of normal and abnormal B cells. Int Immunol 1989;1:229-236.
32. ZOLA H, MELO J, ZOWTYJ H, NIKOLOUTSOPOULOS A, SKINNER J. The leukocyte-common antigen (CD45) complex and B-lymphocyte activation. Human Immunol 1990;27:368-377.
33. YU Y, RABINOWITZ R, POLLIAC A, BEN-BASSAT H, SCHLESINGER M. B-lymphocytes in CLL and NHL differ in the mRNA splicing pattern of the CD45 molecule. Eur J Haematol 2000;64:376-384.
34. AKBAR AN, TERRY L, TIMMS A, BEVERLEY PC, JANOSSY G. Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J Immunol 1988;140:2171-2178.
35. + molecules attain a high concentration in B lymphoma cells and in activated human B cells. Eur J Haematol 2002;68:22-30.